These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6483650)

  • 1. [Selected parameters of the complement system in chronic active hepatitis and liver cirrhosis].
    Zamorska I
    Pol Arch Med Wewn; 1984 May; 71(5):301-12. PubMed ID: 6483650
    [No Abstract]   [Full Text] [Related]  

  • 2. [The C3, C3 Att and C4 fractions of complement in chronic hepatitis: preliminary data].
    Riegler G; Ciotola R; Di Simone A
    Boll Soc Ital Biol Sper; 1976 Feb; 52(4):200-3. PubMed ID: 952675
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complement hemolytic activity (CH50), C3 and C4 levels in serum and plasma of the patients with various liver diseases (author's transl)].
    Fujiwara S
    Nihon Shokakibyo Gakkai Zasshi; 1981 Feb; 78(2):190-9. PubMed ID: 6264183
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinical significance of the C3 component of complement in different variants of viral hepatitis B].
    Antonov TV; Glushkova ES; Iakovlev AA
    Klin Med (Mosk); 1992 Jan; 70(1):78-80. PubMed ID: 1608220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biological significance of serum complements C3 and C4 in HCV-related chronic liver diseases and hepatocellular carcinoma.
    Ali OS; Abo-Shadi MA; Hammad LN
    Egypt J Immunol; 2005; 12(2):91-9. PubMed ID: 17977214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases.
    De Fernandez MA; Clark A; Triger DR
    Clin Exp Immunol; 1987 Mar; 67(3):655-61. PubMed ID: 3608234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The third (C3) and fourth (C4) components of complement in human liver. Immunocytochemical evidence for hepatocytes as the site of synthesis.
    Nagura H; Hasegawa H; Yoshimura S; Watanabe K
    Acta Pathol Jpn; 1985 Jan; 35(1):71-8. PubMed ID: 4003098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoglobulins and C3 and C4 complement components in chronic hepatitis B].
    Stránský J; Votruba T; Zichová M; Vodák M; Benda R
    Cas Lek Cesk; 1985 Nov; 124(47):1445-50. PubMed ID: 4064094
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hepatitis: significance of changes in complement components.
    Charlesworth JA; Lawrence S; Worsdall PA; Roy LP; Boughton CR
    Clin Exp Immunol; 1977 Jun; 28(3):496-501. PubMed ID: 891025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of human ascitic fluid.
    Fromkes JJ; Thomas FB; Mekhjian HS; Evans M
    Gastroenterology; 1977 Oct; 73(4 Pt 1):668-72. PubMed ID: 19339
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of complement activity in chronic liver disease].
    Di Simone A; Coraggio F; Riegler G; Ciotola R
    Minerva Dietol Gastroenterol; 1977; 23(3):137-44. PubMed ID: 618090
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complement C3 and C4 levels in serum from acute viral hepatitis].
    Ozer FT; Barut A; Inal A; Hacibektaşoğlu A
    Mikrobiyol Bul; 1992 Oct; 26(4):314-9. PubMed ID: 1435361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis].
    Hou J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Status of various factors of the complement system in chronic and acute hepatitis].
    Del Rey Calero J; Garcia de Lomas J; Gómez Morillo O; García de Lomas E; Miño G
    Rev Clin Esp; 1976 Jun; 141(6):515-23. PubMed ID: 968086
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum and ascitic concentration of C3, C4 and protein in cirrhotic patients with spontaneous bacterial peritonitis.
    Chen SM; Lo GH; Lai KH; Cheng HH; Cheng JS; Shen MT; Huang RL; Chang CF; Lin CK
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Aug; 54(2):87-92. PubMed ID: 7954051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [C3 and C4 in liver disease].
    Rodríguez Cuartero A; Pérez Blanco F; Rodríguez Cuartero F; Nuñez Carril J
    Rev Esp Enferm Apar Dig; 1981 Apr; 59(4):477-84. PubMed ID: 7268152
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum complements C3 and C4 in chronic HCV infection and their correlation with response to pegylated interferon and ribavirin treatment.
    El-Fatah Fahmy Hanno A; Mohiedeen KM; Deghedy A; Sayed R
    Arab J Gastroenterol; 2014 Jun; 15(2):58-62. PubMed ID: 25097047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology of chronic generalized periodontitis. 2. Estimation of total hemolytic complement (CH 50) and its fractions C3 and C4.
    Anil S; Beena VT; Remani P; Haseenabeevi M; Vijayakumar T
    Indian J Dent Res; 1991; 2(3-4):35-9. PubMed ID: 1821159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic and prognostic value of the assessment of selected indicators of humoral immunity in alcoholism-related pathology of the liver].
    Flisiak R; Boroń-Kaczmarska A; Bobrowska E
    Wiad Lek; 1992 Jun; 45(11-12):418-22. PubMed ID: 1441522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.